Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
European Journal of Haematology|May 3, 2018
Cyclophosphamide's addition in relapsed/refractory multiple myeloma patients with biochemical progression during lenalidomide-dexamethasone treatmentLaura Cesini, Agostina Siniscalchi, Sara Grammatico, et al.Hematological Oncology|March 11, 2009
Comorbidities and FLT3-ITD abnormalities as independent prognostic indicators of survival in elderly acute myeloid leukaemia patientsMassimo Breccia, Anna Maria Frustaci, Laura Cannella, et al.Annals of Hematology|November 8, 2023
Small bowel lesions in patients with iron deficiency anaemia without overt bleeding: a multicentre studyAngelo Zullo, Vincenzo De Francesco, Luigi Gatta, et al.Annals of Hematology|November 1, 2013
A highly specific q-RT-PCR assay to address the relevance of the JAK2WT and JAK2V617F expression levels and control genes in Ph-negative myeloproliferative neoplasmsFrancesca Fantasia, Emma Nora Di Capua, Natalia Cenfra, et al.International Journal of Hematology|August 25, 2009
Decisional flow with a scoring system to start platelet-lowering treatment in patients with essential thrombocythemia: long-term resultsRoberto Latagliata, Angela Rago, Antonio Spadea, et al.Cancer|June 22, 2011
Symptomatic mucocutaneous toxicity of hydroxyurea in Philadelphia chromosome-negative myeloproliferative neoplasms: the Mister Hyde face of a safe drugRoberto Latagliata, Antonio Spadea, Michele Cedrone, et al.Cancers|July 9, 2020
Prognostic Significance of PET/CT in Patients with Chronic Lymphocytic Leukemia (CLL) Treated with Frontline ChemoimmunotherapyMarika Porrazzo, Emanuele Nicolai, Mara Riminucci, et al.Journal of Geriatric Oncology|September 28, 2013
A retrospective study on 73 elderly patients (≥75years) with aggressive B-cell non Hodgkin lymphoma: clinical significance of treatment intensity and comprehensive geriatric assessmentFrancesco Marchesi, Natalia Cenfra, Lidia Altomare, et al.American Journal of Hematology|September 29, 2011
Clinical outcome and monitoring of minimal residual disease in patients with acute lymphoblastic leukemia expressing the MLL/ENL fusion geneLoredana Elia, Sara Grammatico, Francesca Paoloni, et al.European Journal of Haematology|May 23, 2020
Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the "Ph1-negative Myeloproliferative Neoplasms Latium Group"Maria Gabriella Mazzucconi, Ermina Baldacci, Roberto Latagliata, et al.Pageof 5